Axxcess Wealth Management’s Biogen BIIB Stock Holding History

Axxcess Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,281	Closed	-$401K	–	440
2025 Q4	$401K	Buy	+2,281	New	+$373K	0.01%	758

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Axxcess Wealth Management's BIIB Position: Q1 2026 in Review

Axxcess Wealth Management sold out of Biogen (BIIB) in Q1 2026, closing a stake of 2,281 shares — an estimated $401K sold.

Axxcess Wealth Management first reported a position in BIIB in Q4 2025 and held it in 1 quarter. The position peaked at $401K in Q4 2025. 1,008 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

Axxcess Wealth Management reported no remaining Biogen position as of Q1 2026 after selling out during the quarter.
Axxcess Wealth Management sold 2,281 Biogen shares in Q1 2026, an estimated $401K.
Axxcess Wealth Management first reported a position in Biogen in Q4 2025 and held it in 1 quarter.
Axxcess Wealth Management's Biogen position peaked at $401K in Q4 2025.
1,008 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Axxcess Wealth Management's 13F filing for Q1 2026, filed 29 Apr 2026.